Multi-omics resolves a sharp disease-state shift between mild and moderate COVID-19

This article featuring Providence researchers presents an integrated analysis of the clinical measurements, immune cells, and plasma multi-omics of 139 COVID-19 patients representing all levels of disease severity, from serial blood draws collected during the first week of infection following diagnosis. This study suggests that moderate disease may provide the most effective setting for therapeutic intervention.

COVID-19 News & Updates

Get the latest COVID-19 news, important information and updates from health care providers and experts.

1/24/2023
On Tuesday, Jan. 31, Providence Oregon will stop requiring pre-admission COVID testing of most asymptomatic hospital patients. See the details and a review of recent studies supporting the change.
1/26/2023
Evidence outlined in a new research publication co-authored by Dr. Jason Goldman of Providence Swedish could help respond to the shortage of donated organs during COVID-19.
11/29/2022
Learn to identify the differences between RSV, influenza, and COVID-19, and when to treat at home or get medical help.
Initial results, safety data from clinical trial shared during international medical conference